10 results
P
patients who underwent pancreatic surgery
I/C
immunonutrition (IM), standard nutrition (SN)
O
infectious complications, postoperative pancreatic fistula (POPF) rates, length of stay (LOS)
P
voriconazole-treated patients
I/C
cytochrome P450 (CYP) 2C19 polymorphisms, normal metabolizers (NMs) and intermediate metabolizers (IMs)
O
success rate, overall adverse events, hepatotoxicity, neurotoxicity
P
children with chronic myeloid leukemia
I/C
imatinib mesylate, no intervention
O
growth deceleration
P
children, adults
I/C
playing a wind instrument, controls
O
tooth position, facial morphology
P
VOLUNTARY SLOW BREATHING
I/C
VOLUNTARY SLOW BREATHING, NO INTERVENTION
O
INCREASE IN HEART RATE VARIABILITY
P
gilts
I/C
Improvac® vaccine, non-immunized gilts
O
average daily gain, daily feed intake, final live weight, backfat, carcass weight, dressing percentage, lean percentage, intramuscular fat, yield of ham, shoulder, loin, yield of belly
P
12,413 participants
I/C
rabies PrEP and PEP studies, differences in schedules
O
geometric mean titres (GMTs) over time
P
patients with intermediate CAD
I/C
coronary physiology-guided revascularization, angiography-guided revascularization
O
all-cause death, myocardial infarction, target vessel revascularization, major adverse cardiovascular events
P
postmenopausal women
I/C
sexual counselling educational programs, routine care
O
improvement of sexual function